Healthcare Industry News:  S.A. 

Devices Diagnostics FDA Product Launch

 News Release - October 24, 2018

Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device

SAN DIEGO, Oct. 24, 2018 -- (Healthcare Sales & Marketing Network) -- Inova Diagnostics, a world leader in autoimmune diS.A.e diagnostic systemS.A.d reagents for the clinical laboratory, is proud to announce the clearance by the US Food and Drug Administration (FDA) of a Fecal Extraction Device for use in conjunction with QUANTA Flash® Calprotectin. QUANTA Flash Calprotectin aids in the diagnosis of inflammatory bowel diS.A.e (IBD) and helps differentiate IBD from irritable bowel syndrome (IBS). The Fecal Extraction Device is the first calprotectin extraction device to be FDA cleared.

The Fecal Extraction Device iS.A.proprietary, accurate and easy to use device that provides significant workflow improvement to the laboratory compared with manual weighing of samples. The Fecal Extraction Device correlates very well to the manual weighing method, allows extracted sample to be stored up to 72 hourS.A. room temperature, and can be placed directly on the BIO-FLASH system for convenient sample processing. The availability of the Fecal Extraction Device dramatically simplifies the extraction procedure and improves laboratory productivity.

About Inova Diagnostics

Inova Diagnostics iS.A.privately held company headquartered in San Diego, California, and iS.A.part of Werfen, a global leader in in vitro diagnostics (IVD) with a long term commitment to providing innovative solutions for hospitalS.A.d clinical laboratories to improve patient care. Inova Diagnostics manufactures IVD systemS.A.d reagents for autoimmune diS.A.e, and iS.A.leader in the development and commercialization of novel autoimmune technologieS.A.d diagnostic markers. Further information about Inova Diagnostics can be found at www.inovadx.com.

About QUANTA Flash Calprotectin

QUANTA Flash Calprotectin iS.A.chemiluminescence immunoaS.A. performed on BIO-FLASH for the detection of fecal calprotectin in human stool samples. High concentrations of fecal calprotectin, in conjunction with clinical findingS.A.d other laboratory tests, may assist in the diagnosiS.A.d management of IBD (ulcerative colitiS.A.d Crohn's diS.A.e).

About BIO-FLASH

BIO-FLASH iS.A.random access chemiluminescent instrument for the autoimmune laboratory which delivers results in as little as 30 minutes. BIO-FLASH offerS.A.wide analytical measuring range and precise quantification for greater confidence in results, and iS.A.progressive step forward to handle routine, specialized and S.A. immunology tests.

BIO-FLASH iS.A.registered trademark of Biokit S.A. and QUANTA Flash iS.A.trademark of Inova Diagnostics, Inc. © 2018 Inova Diagnostics, Inc. All rights reserved.


Source: Inova Diagnostics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.



RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!